ESR1 and breast cancer: Furthermore, Crippa et al. [47] found that miRNA-342 was significantly associated with estrogen receptor (ER) levels, and it is able to regulate BRCA1 expression through modulation of ID4 in breast cancer, which indicates its important role in diagnosis of IBC.